STLA - Stellantis N.V.
NYSE
->
Consumer Cyclical
->
Auto Manufacturers
Lijnden,
Netherlands
Type: Equity
STLA price evolution
STLA
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $16026 | $14688 | ||
| Inventory | $21414 | $19289 | ||
| Total current assets | $91520 | $95036 | ||
| Long term investments | ||||
| Property, plant & equipment | $37687 | $36193 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $202128 | $198573 | ||
| Current liabilities | ||||
| Accounts payable | $33008 | $34696 | ||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $73940 | $73827 | ||
| Long term debt | $20001 | $20059 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $120435 | $121860 | ||
| Shareholders' equity | ||||
| Retained earnings | $80926 | $72450 | ||
| Other shareholder equity | $3170 | $4906 | ||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $8981 | $9836 | $13176 | $27239.29 |
| Short term investments | ||||
| Net receivables | $16026 | $9446 | $6027 | $6435.72 |
| Inventory | $21414 | $17360 | $11361 | $9245.78 |
| Total current assets | $91520 | $84776 | $74795 | $45752.54 |
| Long term investments | ||||
| Property, plant & equipment | $37687 | $36205 | $35488 | $31506.92 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $68169.04 | |||
| Total investments | ||||
| Total assets | $202128 | $186156 | $171766 | $113921.6 |
| Current liabilities | ||||
| Accounts payable | $33008 | $31726 | $28181 | $23503.96 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $73940 | $66825 | $64857 | $44591.96 |
| Long term debt | $20001 | $19469 | $22624 | $19460.22 |
| Total noncurrent liabilities | $39788.59 | |||
| Total debt | ||||
| Total liabilities | $120435 | $114157 | $115859 | $84380.58 |
| Shareholders' equity | ||||
| Retained earnings | $80926 | $66783 | $52776 | $28351 |
| Other shareholder equity | $3170 | $6107 | $3100 | $29518.17 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $85017 | $91176 | ||
| Cost of revenue | ||||
| Gross Profit | $15199 | $16710 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $7182 | $7394 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $1342 | $1101 | ||
| Interest expense | $404 | $261 | ||
| Net income | ||||
| Net income | $5624 | $7673 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $189544 | $179592 | $149419 | $99009.99 |
| Cost of revenue | ||||
| Gross Profit | $38144 | $36027 | $30908 | $12238.6 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $15034 | $14103 | $13632 | $9687.09 |
| Operating income | $2551.9 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $3793 | $2729 | $1911 | $1521.54 |
| Interest expense | $884 | -$524 | -$610 | $1128.59 |
| Net income | ||||
| Net income | $18596 | $16799 | $14200 | $33.13 |
| Income (for common shares) | ||||
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$8490 | -$15047 | -$5916 | -$10531 |
| Financing activities | ||||
| Dividends paid | -$4651 | -$4208 | -$4208 | -$3353 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$4268 | -$9200 | -$4497 | -$13167 |
| Effect of exchange rate | $425 | -$836 | -$500 | $608 |
| Change in cash and equivalents | -$7344 | -$2764 | $2545 | -$3196 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Net income | $27.42 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $10489.74 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$15047 | -$10531 | $8674 | -$9041.31 |
| Financing activities | ||||
| Dividends paid | -$4208 | -$3353 | -$4204 | |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$9200 | -$13167 | -$1366 | $10380.08 |
| Effect of exchange rate | -$836 | $608 | $764 | -$1728.3 |
| Change in cash and equivalents | -$2764 | -$3196 | $26736 | $10088.79 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |